Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • MD19
    Junior Member
    • Jan 2017
    • 2

    #1

    Why does number of reads per sample vary?

    Hi all,

    I am just starting to learn NGS data analysis.So this may be a very basic question. So in the data for your samples which were normalized in quantity for sequencing run which are expected to have say 10 million reads each, what does it mean if you get a Gaussian distribution averaging at 10million but with +/- 3 million reads? how do you explain that?

    Thanks
  • Bukowski
    Senior Member
    • Jan 2010
    • 388

    #2
    Well - you try pipetting so accurately that you can manage better...

    Quantification isn't exact. Dilution isn't exact. Pooling isn't exact.

    Comment

    • MD19
      Junior Member
      • Jan 2017
      • 2

      #3
      Thanks, Bukowski! Could it also be 'quality of the sample' issue affecting the final output? Just trying to think of all possibilities in this scenario.

      Originally posted by Bukowski View Post
      Well - you try pipetting so accurately that you can manage better...

      Quantification isn't exact. Dilution isn't exact. Pooling isn't exact.

      Comment

      • SNPsaurus
        Registered Vendor
        • May 2013
        • 525

        #4
        Sure, fragmented DNA may make libraries that have a shorter fragment length. Unless you are precise in figuring out how many fragments are in your sample's library, the normalization will be off (and it is a given that you won't be precise at this since fragments can tangle and daisy chain which affects the apparent size distribution. If they are ever pooled and amplified, the short fragments will be enriched in the pool as well.
        Providing nextRAD genotyping and PacBio sequencing services. http://snpsaurus.com

        Comment

        Latest Articles

        Collapse

        • SEQadmin2
          Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
          by SEQadmin2



          Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

          Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
          ...
          10-14-2026, 09:55 AM
        • SEQadmin2
          New Genomics Technologies Take Aim at Long-Standing Limits
          by SEQadmin2


          Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

          We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
          ...
          09-28-2026, 10:25 AM

        ad_right_rmr

        Collapse

        News

        Collapse

        Topics Statistics Last Post
        Started by SEQadmin2, Yesterday, 11:13 AM
        0 responses
        17 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, Yesterday, 10:48 AM
        0 responses
        18 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 10-15-2026, 10:52 AM
        0 responses
        36 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 10-14-2026, 05:39 AM
        0 responses
        42 views
        0 reactions
        Last Post SEQadmin2  
        Working...